5e70ba2109b32d0004a916bd_1.jpg
Todos Medical Receives FDA Certificate of Free Sale for New 5-Day Tollovid Dosing Regimen
May 04, 2021 08:30 ET | Todos Medical Ltd.
Company sees this new dosing regimen of 60 pills over 5 days as optimal for Tollovid, the Company’s 3CL protease inhibitor botanical dietary supplement that helps to support and maintain healthy...
5e70ba2109b32d0004a916bd_1.jpg
Todos Medical Acquires Provista Diagnostics and Its Proprietary Videssa Breast Cancer Blood Test
April 22, 2021 11:35 ET | Todos Medical Ltd.
 Todos plans to commercialize Videssa in late 2021 to reduce unnecessary biopsies in the $7.19 billion mammogram naïve market and integrate it into its TBIA Platform  Provista Diagnostics’ testing...
5e70ba2109b32d0004a916bd_1.jpg
Todos Medical Launches Phase 2 Clinical Trial of Its Antiviral 3CL Protease Inhibitor NLC-V-01 (Tollovir) in Hospitalized COVID-19 Patients
April 19, 2021 10:30 ET | Todos Medical Ltd.
First 10 patients dosed in 77 patient randomized, double blind, placebo controlled Phase 2 Clinical Trial at Shaare Zedek Medical Center in Jerusalem, IsraelData from randomized, placebo controlled,...
5e70ba2109b32d0004a916bd_1.jpg
Todos Medical Receives Notice of Allowance from European Patent Office for Patent Application Covering Diagnosis of Cancer Using Proprietary Artificial Intelligence TBIA Immune Profiling Platform
April 08, 2021 09:27 ET | Todos Medical Ltd.
NEW YORK, NY, and REHOVAT, ISRAEL, April 08, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics solutions company, today announced...
5e70ba2109b32d0004a916bd_1.jpg
Todos Medical Completes Automation Equipment Installation and Training for Meadowlands Diagnostics
April 01, 2021 07:00 ET | Todos Medical Ltd.
·       Minority-owned lab now well positioned to attract and expand institutional contracts with skilled nursing facilities, ambulatory surgery centers, schools & first responders ...
5e70ba2109b32d0004a916bd_1.jpg
Todos Medical Enters Into Distribution Partnership with Osang Healthcare for the GeneFinder Plus™ COVID-19 Plus RealAMP Kit in the United States
March 30, 2021 09:23 ET | Todos Medical Ltd.
GeneFinder Plus has received Emergency Use Authorization from the US FDAAnalysis demonstrates GeneFinder Plus able to detect B.117, B.135, P1 and other variantsValidation ongoing with Saliva,...
5e70ba2109b32d0004a916bd_1.jpg
Todos Medical Completes Automation Equipment Installation and Training for a Laboratory Client in Brooklyn, NY
March 29, 2021 07:20 ET | Todos Medical Ltd.
·       Automation solution increases processing capacity to 6,000 PCR tests per day, expandable to 12,000 daily tests with minor upgrades ·       Client entered into contract with the State of...
5e70ba2109b32d0004a916bd_1.jpg
Todos Medical Enters Into Automation and Reagent Supply Agreement with MAJL Diagnostics
March 23, 2021 08:00 ET | Todos Medical Ltd.
NEW YORK, NY, REHOVAT, ISRAEL, and ATLANTA, GA, March 23, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Todos Medical, Ltd. (OTCQB: TOMDF), an in vitro diagnostics company focused on distributing...
5e70ba2109b32d0004a916bd_1.jpg
Todos Medical Provides Corporate Update
March 17, 2021 12:00 ET | Todos Medical Ltd.
PCR COVID lab sales strengthening as the US prepares to implement serial COVID testing programs to further re-open the economyScaling molecular lab business by deepening COVID offering and...
5e70ba2109b32d0004a916bd_1.jpg
Todos Medical Announces $7.2M in Sales for February 2021, a 38% Month Over Month Increase From Sales of $5.2M in January 2021
March 12, 2021 09:39 ET | Todos Medical Ltd.
·       $12.5M in combined January 2021 and February 2021 sales ·       President Biden signs American Recovery Act into law NEW YORK, NY, REHOVAT, ISRAEL, March 12, 2021 (GLOBE NEWSWIRE) -- via...